Neurocrine Biosciences Inc Liquidation Value
NBIX
Other
Cash & Equivalents
$713.00M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $713.00M
Total Obligations: -$1.21B
$-501.70M
Per share: $-5.01
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $713.00M
AR: $686.80M
Total Obligations: -$1.21B
$185.10M
Per share: $1.85
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $713.00M
AR: $686.80M
Inventory: $69.00M
Total Obligations: -$1.21B
$254.10M
Per share: $2.54
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-501.70M | $-5.01 |
| Liquid Liquidation Value | $185.10M | $1.85 |
| Operating Liquidation Value | $254.10M | $2.54 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $713.00M |
| Accounts Receivable | $686.80M |
| Inventory | $69.00M |
| Current Liabilities | $743.40M |
| Long-term Debt | $170.40M |
| Op. Lease Liability | $471.30M |
| Finance Lease | N/A |
| Shares Outstanding | 100.1M |
Explore all 214 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $713.00M | $686.80M | $69.00M | N/A | $743.40M | N/A | $471.30M | N/A |
| 2025-09-30 | $340.20M | $728.00M | $69.30M | N/A | $638.00M | N/A | $479.70M | N/A |
| 2025-06-30 | $264.00M | $595.70M | $56.90M | N/A | $546.30M | N/A | $489.80M | N/A |
| 2025-03-31 | $194.10M | $516.00M | $59.10M | N/A | $522.90M | N/A | $493.10M | N/A |
| 2024-12-31 | $233.00M | $479.10M | $57.40M | N/A | $507.70M | N/A | $495.70M | N/A |
| 2024-09-30 | $349.10M | $481.10M | $45.80M | N/A | $429.70M | N/A | $286.20M | N/A |
| 2024-06-30 | $139.70M | $468.20M | $42.50M | N/A | $398.50M | N/A | $291.60M | N/A |
| 2024-03-31 | $396.30M | $450.70M | $37.20M | N/A | $712.90M | $170.40M | $287.90M | N/A |
▼ Community Notes